Monday , September 23 2019
Home / argentina / Chile Delivers Pills to Prevent Spread of HIV | NEWS | Industry

Chile Delivers Pills to Prevent Spread of HIV | NEWS | Industry

Chilean government announced last Friday free shipping of pre-exposure prevention tablets (PrEP)medication that prevents HIV transmission; during first quarter of 2019

To this end, the authorities of Chile, a country in which the number of people infected with this virus has been duplicated over the past seven years, met with members Homosexual Integration and Liberation Movement (Movilh), in order to determine the protocols that govern its use in the next year.

"PrEP tablets can reduce the likelihood of contracting a virus by more than 90% during sexual practices if it is taken dailyTherefore, there should be a protocol that guides people about its real consequences and encourages them to prefer safe sexual practices, because they don’t have the idea that pills can relax, ”said Movilh Medical Center manager Diego Rios.

According to the Minister of Health, Emilio santelicesThe PrEP tablet is part of a new plan to combat AIDS and HIV and will be used as a preventive treatment in high-risk groups.

How it works?

According to the US Centers for Disease Control and Prevention (CDC), if PrEP is taken daily, you get reduce by more than 90% the likelihood of contracting the virus that causes AIDS, sexually or 70% through the use of needles that are not sterilized or used by several people.

PrEP contains emtricitabine and tenofovirtwo drugs that are also used in antiretroviral drugs, because they reduce the amount of virus in the blood and prevent its multiplication.

The pills do not act as a vaccine because they do not generate antibodies, but rather because their daily consumption is necessary so that emtricitabine and tenofovir are present in the blood at the time of infection and prevent the formation of HIV in the body.

Before ingestion, it is necessary to check the good condition of the kidneys and liver, since tablets can cause disorders in these organs.

More information

It was the American pharmaceutical company Gilead Sciences that began selling this medicine in 2012 under the brand name TruvadaIt is estimated that the commercial value of the monthly treatment reaches $ 600.

Years later, the World Health Organization (WHO) began recommending its use for HIV prevention among high-risk groups such as sex workers or couples of infected patients.


According to Onusida, which dates back to 2017, there are 67,000 people living with HIV in Chile, of whom 39,001 are on treatment, and forecasts indicate an increase in the number of victims to 100,000 by the end of this year.

Source link